SCHEMBL3326587

SCHEMBL3326587

CC[C@H](O)C1CCCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
KMT2A Q03164 1/20 0.51
HPGD P15428 1/20 0.46
EPHX1 P07099 1/20 0.44
PRMT5 O14744 1/20 0.42
WDR77 Q9BQA1 1/20 0.42
USP30 Q70CQ3 2/20 0.42
GPR119 Q8TDV5 2/20 0.41
NR1H2 P55055 1/20 0.40
DPP4 P27487 1/20 0.40
TRPV3 Q8NET8 1/20 0.40
GLS O94925 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
PREP P48147 1/20 0.39
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
BRD4 O60885 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27751585 1.00 MEN1 (0.51) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL3326579 1.00 MEN1 (0.51) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL8537525 1.00 MEN1 (0.51) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL3323969 1.00 MEN1 (0.51) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL3323977 1.00 MEN1 (0.51) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL1058770 0.93 GPR119 (0.46) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL1058771 0.93 GPR119 (0.46) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL1054992 0.93 GPR119 (0.46) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL1054993 0.93 GPR119 (0.46) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL23274915 0.88 MEN1 (0.50) MEN1ALDH1A1MAPTKMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120858-A1 Piperidine Derivatives PFIZER INC. 2010-05-13 US disclosed
EP-2066630-A1 PIPERIDINE DERIVATIVES Pfizer Products Incorporated (US) 2009-06-10 EP disclosed
WO-2008023258-A1 PIPERIDINE DERIVATIVES PFIZER PRODUCTS INC. (US) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120858-A1 Piperidine Derivatives P2RX5, P2RX7, P2RX1 MEN1 2104/4885ALDH1A1 128/4885MAPT 3998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.